Vivimed Labs Limited

₹5.41As of Sun 8 Nov 2026, 12:00 UTC
NSE:VIVIMEDLABHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.81
PE TTM —
TSR TTM —
Mkt cap ₹448.6M
ROIC (56.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹5.29
(2.25%)
(85.74%)
Hold 9|1|5|3|9
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.14
0.14
0.14
0.15
16.87%
7.55%
5.82%
14.95%
Revenue₹M
54.92
57.91
57.20
55.70
7.63%
8.81%
10.50%
7.02%
Peers (US$4.777M)
Cap (US$)
PE
4.954M
—
4.830M
0.121x
Capital
TTM
5Y
10Y
Leveragex
1.021
0.568
0.538
EBIT/Intx
0.209
0.195
0.231
Own earn%
279.41
23.75
(0.07)
Sh yield%
38.00
3.24
4.22
Owners
Insiders/Inst%
0.77
38.62
Short interest%
1.70
SBC / revenue%
3.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
4–13
$1 testx
—
Incr. ROIC%
2